Gene Research, Inc., just finished a 4-year program of R&D and clinical trial. It ex- pects a quick approval from the Food and Drug Administration. If Gene markets the product its own, the company will require $30 million immediately (n = 0) to build a new manufacturing facility, and it is expected to have a 10-year product life. The R&D expenditure in the previous years and the anticipated revenues that the company can generate over the next 10 years are summarized as follows: Cash Flow (Unit: $ million) Period (n) -4 -$10 -3 -10 -2 -10 -1 -10 -10 – 30 1–10 100 Merck, a large drug company is interested, in purchasing the R&D project and the right to commercialize the product from Gene Research, Inc.; it wants to do so immediately (n = 0). What would be a starting negotiating price for the project from Merck? Assume that Gene's MARR = 20%.

Essentials Of Investments
11th Edition
ISBN:9781260013924
Author:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Chapter1: Investments: Background And Issues
Section: Chapter Questions
Problem 1PS
icon
Related questions
Question

q5.20

5.20 Gene Research, Inc., just finished a 4-year program of R&D and clinical trial. It ex-
pects a quick approval from the Food and Drug Administration. If Gene markets
the product its own, the company will require $30 million immediately (n = 0) to
build a new manufacturing facility, and it is expected to have a 10-year product life.
The R&D expenditure in the previous years and the anticipated revenues that the
company can generate over the next 10 years are summarized as follows:
Cash Flow
Period (n)
(Unit: $ million)
-4
-$10
-3
-10
-2
-10
-1
-10
-10 – 30
1–10
100
Merck, a large drug company is interested, in purchasing the R&D project and the
right to commercialize the product from Gene Research, Inc.; it wants to do so
immediately (n = 0). What would be a starting negotiating price for the project
from Merck? Assume that Gene's MARR = 20%.
Transcribed Image Text:5.20 Gene Research, Inc., just finished a 4-year program of R&D and clinical trial. It ex- pects a quick approval from the Food and Drug Administration. If Gene markets the product its own, the company will require $30 million immediately (n = 0) to build a new manufacturing facility, and it is expected to have a 10-year product life. The R&D expenditure in the previous years and the anticipated revenues that the company can generate over the next 10 years are summarized as follows: Cash Flow Period (n) (Unit: $ million) -4 -$10 -3 -10 -2 -10 -1 -10 -10 – 30 1–10 100 Merck, a large drug company is interested, in purchasing the R&D project and the right to commercialize the product from Gene Research, Inc.; it wants to do so immediately (n = 0). What would be a starting negotiating price for the project from Merck? Assume that Gene's MARR = 20%.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps with 2 images

Blurred answer
Knowledge Booster
Accounting for Financial Instruments
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Essentials Of Investments
Essentials Of Investments
Finance
ISBN:
9781260013924
Author:
Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:
Mcgraw-hill Education,
FUNDAMENTALS OF CORPORATE FINANCE
FUNDAMENTALS OF CORPORATE FINANCE
Finance
ISBN:
9781260013962
Author:
BREALEY
Publisher:
RENT MCG
Financial Management: Theory & Practice
Financial Management: Theory & Practice
Finance
ISBN:
9781337909730
Author:
Brigham
Publisher:
Cengage
Foundations Of Finance
Foundations Of Finance
Finance
ISBN:
9780134897264
Author:
KEOWN, Arthur J., Martin, John D., PETTY, J. William
Publisher:
Pearson,
Fundamentals of Financial Management (MindTap Cou…
Fundamentals of Financial Management (MindTap Cou…
Finance
ISBN:
9781337395250
Author:
Eugene F. Brigham, Joel F. Houston
Publisher:
Cengage Learning
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Finance
ISBN:
9780077861759
Author:
Stephen A. Ross Franco Modigliani Professor of Financial Economics Professor, Randolph W Westerfield Robert R. Dockson Deans Chair in Bus. Admin., Jeffrey Jaffe, Bradford D Jordan Professor
Publisher:
McGraw-Hill Education